Disclosed are novel A2B adenosine receptor antagonists having the structure of Formula I or Formula II: ##STR1##

The compounds are particularly useful for treating asthma, inflammatory gastrointestinal tract disorders, cardiovascular diseases, neurological disorders, and diseases related to undesirable angiogenesis.

 
Web www.patentalert.com

< SH2 domain binding inhibitors

< Substituted piperidines and methods of use

> System and method for stimulation of a person's brain stem

> Secreted and transmembrane polypeptides and nucleic acids encoding the same

~ 00227